Merck Sharp & Dohme signs cooperation agreement with Eifang Biotechnology to advance clinical development of small molecule drugs in the field of oncology.

According to Merck China, on August 10, Merck Research Laboratories announced the signing of a cooperation agreement with Eifong Biotechnology. The two parties will jointly advance the clinical development of small molecule drugs in the oncology field, opening new possibilities for cancer treatment.